Gemäß den neuesten Finanzberichten von Taro Pharmaceutical betragen die Gesamtschulden des Unternehmens €1.68 Million Euro. Die Gesamtschulden eines Unternehmens sind die Summe aller kurzfristigen und langfristigen Schulden.
Jahr | Gesamtschulden | Veränderung |
---|---|---|
2023-03-31 | €1.79 Mio. | -9.82% |
2022-03-31 | €1.99 Mio. | 38.23% |
2021-03-31 | €1.44 Mio. | 4.88% |
2020-03-31 | €1.37 Mio. | |
2019-03-31 | N/A | |
2015-03-31 | €5.48 Mio. | -57.71% |
2014-03-31 | €12.96 Mio. | -41.94% |
2013-03-31 | €22.33 Mio. | |
2011-12-31 | €34.41 Mio. | -22.97% |
2010-12-31 | €44.67 Mio. | -60.91% |
2009-12-31 | €0.11 Mrd. | -15.02% |
2008-12-31 | €0.13 Mrd. | -9.38% |
2007-12-31 | €0.14 Mrd. | -17.76% |
2006-12-31 | €0.18 Mrd. | -18.38% |
2005-12-31 | €0.22 Mrd. | 11.4% |
2004-12-31 | €0.19 Mrd. | 24.65% |
2003-12-31 | €0.15 Mrd. | 190% |
2002-12-31 | €54.9 Mio. | -5.85% |
2001-12-31 | €58.32 Mio. | 17.54% |
2000-12-31 | €49.61 Mio. | 43.78% |
1999-12-31 | €34.5 Mio. | 24.47% |
1998-12-31 | €27.72 Mio. | 10.4% |
1997-12-31 | €25.11 Mio. | 25.74% |
1996-12-31 | €19.97 Mio. |
Unternehmen | Gesamtschulden/th> | DifferenzDiff. | Land |
---|---|---|---|
![]() Pfizer PFE | €52.87 Mrd. | 3,143,028.21% | 🇺🇸 USA |
![]() Merck MRK | €30.05 Mrd. | 1,786,771.79% | 🇺🇸 USA |
![]() Johnson & Johnson JNJ | €45.07 Mrd. | 2,679,489.74% | 🇺🇸 USA |
![]() Teva Pharmaceutical Industries TEVA | €14.61 Mrd. | 868,566.67% | 🇮🇱 Israel |
![]() GlaxoSmithKline GSK | €20.54 Mrd. | 1,221,223.08% | 🇬🇧 UK |
![]() Novartis NVS | €26.97 Mrd. | 1,603,489.74% | 🇨🇭 Switzerland |